Provider
Ellume began recalling the tests last month for giving false positive results.
The tool uses information about pain level, condition and current medication regimen to find an effective dose of opioids.
Third-party developers can use the platform to build their own products or update instruments.
The scheme is being run in partnership with government technology firm PUBLIC.
The pair aim to make AI-enhanced diagnostics accessible beyond hospital settings.
The two companies will also collaborate on a clinical study using AI mammography.
HoneyNaps claims its software provides more accurate readings than conventional auto-scoring.
Also, Indian voice AI platform Augnito has introduced its voice AI SaaS during the Diwali.
A new app which collates older people’s health indicators and monitors for flu symptoms supports nurses and carers to make remote diagnoses and treat patients in their homes, reducing hospitalisations.
The internet cognitive behavioural therapy programme will launch in 2022.